Clinical Trials Logo

Refractory Respiratory Failure clinical trials

View clinical trials related to Refractory Respiratory Failure.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06010446 Completed - Clinical trials for Refractory Respiratory Failure

Intravenous Continuous LMWH Seems to be Safe Alternative to UFH in VV ECMO Patients

Start date: May 15, 2019
Phase:
Study type: Observational

Unfractionated heparin (UFH) is worldwide anticoagulation used and recommended anticoagulation in patients with ECMO support. However, it is accompanied with incidence of bleeding or thrombotic compliaction at about 40-60% and high mortality. Because ECMO produce primary haemosthasis pathology, there is a theory that prophylaxis of thrombosis with low molecular weight heparin (LMWH) e.g. Enoxaparin might be sufficient to prevent ECMO throbosis and thrombosis development in patients. We decided to performed retrospective observation study and analysis of data, from may 2019 until august 2023, in all patients who were put on VV ECMO and to analysis incidence of bleeding, thrombotic and neurologic complications.

NCT ID: NCT03135210 Completed - Clinical trials for Refractory Respiratory Failure

Leg Exercise During ECMO

ECMO
Start date: November 13, 2017
Phase: N/A
Study type: Interventional

Patients undergoing extracorporeal membrane oxygenation (ECMO) are at high risk for deconditioning and functional decline. The primary aim of this study is to assess the functional impact of leg exercise during the pre-ambulation phase in patients undergoing ECMO.